Health & Medical Rheumatoid Arthritis

Treatment of Spondyloarthropathy

Treatment of Spondyloarthropathy

B Cell (Rituximab)


Rituximab, which is a chimeric anti-CD20 monoclonal antibody, has been proven effective in RA. Interestingly, although immunohistochemical stains of sacroiliac joint biopsies from SpA patients showed that T cells and macrophages were most frequent cells, the number of CD20+ B cells in the persistent inflamed joint from AS patients has been reported to be significantly higher than joints from controls or joints from AS patients without active inflammation.

Whether rituximab may be effective in SpA is presently unclear. In an open-label trial of rituximab in AS, rituximab was not ineffective for10 patients who were refractory to TNF inhibitors; at 24 weeks, 30% of patients achieved an Assessment of SpondyloArthritis International Society (ASAS) 20 response, a level typical of placebo in controlled trials. In 10 patients naïve to TNF inhibitors, there was modest efficacy, with 50% achieving an ASAS 20 response and 30% achieving partial remission. Among nine patients achieving ASAS 20 response (six TNF-α blocker naïve, three TNF-α blocker failure), five patients flared and received a second course of rituximab. Interestingly, patients had more improvement compared with the first course. In a retrospective analysis of the French registry data, among 26 SpA patients, rituximab showed only modest efficacy, and mostly among those patients naïve to TNF inhibitors.

In an open-label study of rituximab in psoriatic arthritis (PsA) patients, the primary end point – at least 30% improvement by PsA response criteria – was achieved by five of the nine patients. In another open-label study, the efficacy of rituximab for 21 patients with PsA modest improvement in arthritis and psoriasis was observed, especially in TNF inhibitor-naïve patients. At week 24, American College of Rheumatology (ACR) 20 responders were 30% of patients and Psoriasis Area and Severity Index (PASI) 75 responders were 15% of patients. Larger controlled studies are required to confirm the potential effect of rituximab in PsA.

SHARE
RELATED POSTS on "Health & Medical"
Glucosamine and Chondroitin-Topic Overview
Glucosamine and Chondroitin-Topic Overview
Diagnosing Knee Arthritis and Treatment
Diagnosing Knee Arthritis and Treatment
Arthritis Can Erode Your Self-Esteem as Well as Your Joints
Arthritis Can Erode Your Self-Esteem as Well as Your Joints
Rheumatoid Arthritis Tips
Rheumatoid Arthritis Tips
Understanding Arthritis
Understanding Arthritis
Natural Gout Cures Or How to Cure The Pain In Your Big Toe
Natural Gout Cures Or How to Cure The Pain In Your Big Toe
Green Tea vs. Rheumatoid Arthritis
Green Tea vs. Rheumatoid Arthritis
The Essence of Exercise in Ankylosing Spondylitis
The Essence of Exercise in Ankylosing Spondylitis
Raynaud's Phenomenon-Credits
Raynaud's Phenomenon-Credits
Methotrexate in Combination or Alone for Early RA Remission?
Methotrexate in Combination or Alone for Early RA Remission?
Treatments for Juvenile Rheumatoid Arthritis
Treatments for Juvenile Rheumatoid Arthritis
Women's Knee-Injury Mystery Unsolved
Women's Knee-Injury Mystery Unsolved
How Is RA or SLE Differentially Diagnosed?
How Is RA or SLE Differentially Diagnosed?
Can Natural Gout Treatment Work for Everyone?
Can Natural Gout Treatment Work for Everyone?
How to Lower Uric Acid Symptoms of Gout Using This Simple Fruit
How to Lower Uric Acid Symptoms of Gout Using This Simple Fruit
Knee Factor
Knee Factor
Low Uric Acid Diet - How a Low Uric Acid Diet Can Relieve Your Gout
Low Uric Acid Diet - How a Low Uric Acid Diet Can Relieve Your Gout
Hip Joint Pain?
Hip Joint Pain?
Arthritis Diagnosis and Treatment in Austin
Arthritis Diagnosis and Treatment in Austin
Herbal Remedies for Arthritis
Herbal Remedies for Arthritis

Leave Your Reply

*